Founders Capital Management
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1704300
HOUSTON, TX
Position in CPRX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$18,858
+$4,002 QoQ
Shares Held
600
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 55 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Founders Capital Management holds $121,159 across 7 Biotechnology names. CPRX ranks #4 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
1,400 | $38,458 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
2,500 | $24,550 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
|
16,000 | $20,960 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
600 | $18,858 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
300 | $11,703 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
1,667 | $5,667 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
4 | $963 |
All Filings in CPRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,858 | 600 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $14,856 | 600 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $14,004 | 600 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $11,820 | 600 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||